10 insiders reported 35 Form 4 transactions for ZEVRA THERAPEUTICS, INC. (ZVRA) over the past 18 months (most recent 2026-08-17). Recent activity: Thompson Rahsaan (Chief Legal & Compliance) Sell 42,666 shares, Watton Corey Michael (Director) Buy 12,300 shares, Watton Corey Michael (Director) Sell 12,300 shares, Thompson Rahsaan (Chief Legal & Compliance) Buy 66,667 shares, Thompson Rahsaan (Chief Legal & Compliance) Sell 34,557 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | Thompson Rahsaan | Chief Legal & Compliance | Sell | 42,666 | $474,774 |
| 2026-08-12 | Watton Corey Michael | Director | Buy | 12,300 | $61,131 |
| 2026-08-12 | Watton Corey Michael | Director | Sell | 12,300 | $138,377 |
| 2026-06-23 | Thompson Rahsaan | Chief Legal & Compliance | Buy | 66,667 | $0 |
| 2026-06-23 | Thompson Rahsaan | Chief Legal & Compliance | Sell | 34,557 | $438,304 |
| 2026-05-13 | Thompson Rahsaan | Chief Legal & Compliance | Sell | 1,794 | $20,272 |
| 2026-03-26 | Bode John B | Director | Buy | 39,200 | $194,824 |
| 2026-03-26 | Bode John B | Director | Buy | 39,200 | $191,688 |
| 2026-02-10 | McFarlane Neil F. | President and CEO | Buy | 37,500 | $0 |
| 2026-02-10 | McFarlane Neil F. | President and CEO | Sell | 14,625 | $125,190 |
| 2026-02-04 | Schafer Joshua | CCO | Sell | 10,500 | $96,495 |
| 2026-02-04 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Sell | 3,000 | $27,540 |
| 2026-02-02 | McFarlane Neil F. | President and CEO | Sell | 91,000 | $853,580 |
| 2026-02-02 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Buy | 6,333 | $0 |
| 2026-02-02 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Sell | 1,750 | $15,435 |
| 2026-02-02 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Buy | 11,666 | $0 |
| 2026-02-02 | Schafer Joshua | CCO | Buy | 11,333 | $0 |
| 2026-02-02 | Schafer Joshua | CCO | Sell | 3,375 | $29,801 |
| 2026-02-02 | Schafer Joshua | CCO | Buy | 35,334 | $0 |
| 2026-02-02 | Thompson Rahsaan | Chief Legal & Compliance | Buy | 11,333 | $0 |
| 2026-02-02 | Thompson Rahsaan | Chief Legal & Compliance | Sell | 4,080 | $36,026 |
| 2026-02-02 | Quartel Adrian W | Chief Medical Officer | Buy | 11,333 | $0 |
| 2026-02-02 | Quartel Adrian W | Chief Medical Officer | Sell | 4,533 | $40,026 |
| 2026-02-02 | McFarlane Neil F. | President and CEO | Buy | 233,334 | $0 |
| 2026-01-07 | Clifton R. LaDuane | Insider | Buy | 140,667 | $0 |
Source: SEC Form 4 filings · as of 2026-08-17